Mytaxel 260Mg/43.3Ml Inj Substitute
by Others
by Others
by Others
by AYUR
by Others
by AYUR
by Others
by Others
by Others
by Others
by Others
by AYUR
by Others
by Others
by Others
Composition:
PACLITAXEL-260MG
Uses:
Ovarian cancer, breast cancer, non-small cell lung cancer.
Medicinal Benefits:
Mytaxel 260Mg/43.3Ml Inj belongs to the group of anti-cancer medicines called anti-microtubule agents used to treat various types of cancers, including ovarian and breast cancer (in advanced/spreading state or after surgery) and advanced-stage non-small cell lung cancer. It may also be used when other treatments have failed or in combination with other treatments. Mytaxel 260Mg/43.3Ml Inj may also be indicated in patients with Kaposi’s sarcoma (cancer that develops from the cells that line lymph or blood vessels) associated with AIDS (Acquired Immuno-Deficiency Syndrome), where other treatments have not been effective. Mytaxel 260Mg/43.3Ml Inj contains ‘Paclitaxel’, which works by preventing the growth of certain cancer cells.
Mytaxel 260Mg/43.3Ml Inj works by stopping cell division and preventing the growth of certain cancer cells.
Mytaxel 260Mg/43.3Ml Inj might cause sterility which could be permanent. Please talk to your doctor if you have any concerns.
The most common side effect of Mytaxel 260Mg/43.3Ml Inj is hair loss. The hair may grow back after the treatment with Mytaxel 260Mg/43.3Ml Inj is finished. However, consult your doctor if you have any concerns.